BioCardia, Inc. BCDA
Set alert
0.94 USD +0.08 +8.98%
As of Nov 2, 3:58 PM ET
0.86 Day range 0.9999
0.75 52-week range 1.80
- YTD
- -24.94%
- 1 year
- -32.98%
- Open
- 0.8675
- Prev close
- 0.861
- Mkt cap
- 14.20M
- Vol
- 81.66K
- Avg vol
- 242.52K
- EPS
- -0.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.86
- High
- 0.9999
- Forward P/E
- -1.57
- Beta
- 1.27
- Short ratio
- 1.41
- Inst. own
- 2.21%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.28
- 200-d avg
- 3.62
- 1y target
- 25.00
6M chart
Signals (22)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| RSI: Overbought | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| RSI: Overbought | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 16, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| RSI: Oversold | May 21, 2026 | 5 months ago |
| RSI: Oversold | May 18, 2026 | 5 months ago |
Financial health
Altman Z-Score
-51.43 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E -1.0×
FY 2016 5y median -1.2× FY 2025
P/S 0.0×
FY 2016 5y median 82.2× FY 2025
P/B 9.3×
FY 2016 5y median 9.3× FY 2025
P/FCF -1.1×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -0.8×
FY 2016 5y median -1.2× FY 2025
EV/Sales 0.0×
FY 2016 5y median 77.9× FY 2025
FCF Yield -89.3%
FY 2016 5y median -71.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median -553.4% FY 2025
Operating Margin 0.0%
FY 2016 5y median -1244.3% FY 2025
Net Margin 0.0%
FY 2016 5y median -1243.4% FY 2025
ROE -919.3%
FY 2016 5y median -243.4% FY 2025
ROIC -581.7%
FY 2016 5y median -182.5% FY 2025
ROA -241.1%
FY 2016 5y median -213.4% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2016 FY 2025
Operating Income -3.5%
FY 2016 FY 2025
EPS (diluted) 57.6%
FY 2016 FY 2025
Free Cash Flow 7.3%
FY 2016 FY 2025
Financial Health
Current Ratio 1.1×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 0.3×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31